Login
$CRDL
$1.12 +$0.00 (0.0%) Close

Ownership

13F as of Q2 2026 · 100.3M shares outstanding

Who owns CRDL?

By type of holder
Institutions 29.4% Everyone else 70.6%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 28.3%
MMCAP International Inc. SPC 15.6% · Tejara Capital Ltd 5.1%
Institutional ownership
29.4%
+1.6 pts vs last qtr
Institutional holders
51
+4 vs last qtr
Net shares bought
+1.6M
by institutions in Q2 2026
New / sold out
11 / 7
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Ikarian Capital, LLC +600.0K
  • Renaissance Technologies LLC +543.0K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Knoll Capital Management, LLC SOLD OUT −100.0K
  • Integrity Alliance, LLC. −76.5K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Cardiol Therapeutics Inc in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Cardiol Therapeutics Inc.

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years72% 1–3 years2% Under 1 year26%
Quarterly turnover
4.6%
of institutional shares changed hands
Top 10 managers, median time held
3 quarters

Super Investors

Investment managers reporting CRDL on Form 13F
MI
MMCAP International Inc. SPC
Shares
15.6M
% of company
15.56%
Change vs last qtr
+246.2K (+1.6%)
Held since
2021
TC
Tejara Capital Ltd
Shares
5.1M
% of company
5.10%
Change vs last qtr
−16.3K (−0.3%)
Held since
2022

28 more super investors behind a free account

See every manager holding Cardiol Therapeutics Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting CRDL on Form N-PORT; together they hold 0.0% of the company
FN
Fidelity Concord Street Trust
Position value
$36.5K
% of company
0.02%
% of the fund
0.00%
As of
August 31, 2026

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support